Litcius/Paper detail

Comparing the clinical outcomes across different sodium/glucose cotransporter 2 (SGLT2) inhibitors in heart failure patients: a systematic review and network meta-analysis of randomized controlled trials

Yao Hao Teo, Celine Shuen Yin Yoong, Nicholas Syn, Yao Neng Teo, Jia Yang Alex Cheong, Yoke-Ching Lim, Chi‐Hang Lee, Tiong‐Cheng Yeo, Ping Chai, Raymond Wong, Weiqin Lin, Ching‐Hui Sia

2021European Journal of Clinical Pharmacology29 citationsDOI

Topics & Concepts

MedicineEmpagliflozinCanagliflozinHeart failureDapagliflozinInternal medicineRandomized controlled trialMeta-analysisMyocardial infarctionStroke (engine)Renal functionCardiologyHazard ratioIntensive care medicineDiabetes mellitusConfidence intervalType 2 diabetesEndocrinologyMechanical engineeringEngineeringDiabetes Treatment and ManagementHeart Failure Treatment and ManagementPancreatic function and diabetes
Comparing the clinical outcomes across different sodium/glucose cotransporter 2 (SGLT2) inhibitors in heart failure patients: a systematic review and network meta-analysis of randomized controlled trials | Litcius